Consequently, our observation, the persistent and robust activation of the IFN system by HDV, might explain, at least in part, the accelerated progression of liver fibrosis and the increased risk of developing end-stage liver diseases seen in patients with chronic HBV-HDV infection. This evidence concerns the gene IFNA1 and End Stage Liver Disease.